Filters
Other countries
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Nijmegen breakage syndrome (deletion/duplication analysis on NBN gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
SLC38A8 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Centogene AG - the Rare Disease Company Germany | 157 | 151 |
|
Invitae Oculocutaneous Albinism Panel Invitae United States | 28 | 22 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Invitae Hypopigmentation Panel Invitae United States | 83 | 46 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics, part of Exact Sciences United States | 272 | 278 |
|
PreventionGenetics, part of Exact Sciences United States | 39 | 33 |
|
Invitae Microphthalmia, Anophthalmia, Coloboma (MAC) and Anterior Segment Dysgenesis Panel Invitae United States | 130 | 81 |
|
Isolated Foveal Hypoplasia Type 2 (FVH2) via the SLC38A8 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Neuro-ophthalmology panel. NGS panel of 38 genes. Genologica Medica Spain | 75 | 38 |
|
Foveal hypoplasia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
Foveal Hypoplasia and Presenile Cataract Syndrome Type 2 , Sequencing SLC38A8 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Anophthalmia/Microphthalmia/Coloboma/Anterior Segment Dysgenesis Asper Biogene Asper Biogene LLC Estonia | 37 | 35 |
|
Hermansky-Pudlak Syndrome/Oculocutaneous Albinism/Pigmentation panel Molecular Vision Laboratory United States | 45 | 29 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.